BE894228A - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS - Google Patents

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS

Info

Publication number
BE894228A
BE894228A BE0/208897A BE208897A BE894228A BE 894228 A BE894228 A BE 894228A BE 0/208897 A BE0/208897 A BE 0/208897A BE 208897 A BE208897 A BE 208897A BE 894228 A BE894228 A BE 894228A
Authority
BE
Belgium
Prior art keywords
atherosclerosis
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BE0/208897A
Other languages
French (fr)
Original Assignee
Coughlin Shaun R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coughlin Shaun R filed Critical Coughlin Shaun R
Publication of BE894228A publication Critical patent/BE894228A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
BE0/208897A 1981-08-27 1982-08-27 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS BE894228A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29707681A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
BE894228A true BE894228A (en) 1982-12-16

Family

ID=23144754

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208897A BE894228A (en) 1981-08-27 1982-08-27 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS

Country Status (7)

Country Link
JP (1) JPS5865224A (en)
AU (1) AU8770282A (en)
BE (1) BE894228A (en)
DE (1) DE3232031A1 (en)
FR (1) FR2511869A1 (en)
GB (1) GB2105192A (en)
IT (1) IT1153185B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1233412B (en) * 1987-12-02 1992-03-30 Acraf USE OF TRAZODONE
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE19900674A1 (en) * 1999-01-11 2000-07-13 Basf Ag Binding partner for 5-HT5 receptors for migraine treatment
DE10043124A1 (en) 2000-08-31 2002-03-14 Max Delbrueck Centrum Methods for the diagnosis of neuronal diseases and for the treatment of deficient primary hemostasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH553161A (en) * 1970-10-30 1974-08-30 Hoffmann La Roche PROCESS FOR PRODUCING PHENYLALANINE DERIVATIVES.
DE2930369A1 (en) * 1979-07-26 1981-02-05 Rentschler Arzneimittel MEDICINE SOLUTIONS

Also Published As

Publication number Publication date
DE3232031A1 (en) 1983-05-05
JPS5865224A (en) 1983-04-18
IT1153185B (en) 1987-01-14
AU8770282A (en) 1983-03-03
IT8223020A0 (en) 1982-08-27
GB2105192A (en) 1983-03-23
FR2511869A1 (en) 1983-03-04

Similar Documents

Publication Publication Date Title
BE890648A (en) COMPOSITIONS FOR THE TREATMENT OF ACNE
BE851328A (en) COMPOSITION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
FR2508318B1 (en) BANDAGE FOR THE ADMINISTRATION OF A PHARMACEUTICAL SUBSTANCE
FR2503562B1 (en) PHARMACEUTICAL CONDITIONING FOR THE TREATMENT OF MENOPAUSE SYMPTOMS
MA18939A1 (en) PROCESS FOR THE PREPARATION OF AN AGENT FOR THE TREATMENT OF THEILERIOSES
PT75499B (en) PROCESS FOR THE PREPARATION OF ALKANOILANILIDES
FR2499408B1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OSTEOPATHY, BASED ON 6-AMINO-1-HYDROXYHEXANE-1,1-DIPHOSPHONIC ACID
MC1525A1 (en) PREPARATION OF A COMPOSITION FOR THE TREATMENT OF SEBORRHEA
FR2558372B1 (en) DRUG COMPOSITION FOR THE TREATMENT OF ACNE
BE894228A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS
MA20655A1 (en) COMPOSITIONS FOR THE TREATMENT OF TEXTILES
FR2536995B1 (en) COMPOSITION FOR THE TREATMENT OF ARTHRITIS
BE872908A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION
FR2340737A1 (en) COMPOSITION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
BE894172A (en) COMPOSITIONS FOR THE TREATMENT OF AMIDINO-UREA COCCIDIOSIS
FR2526792B1 (en) ALETHEIN DERIVATIVES USEFUL FOR THE TREATMENT OF HEPATIC LESIONS
FR2544614B1 (en) NEW DRUG ASSOCIATION FOR THE TREATMENT OF HYPERTENSION
FR2517203B1 (en) COMPOSITION FOR THE TREATMENT OF ACNE
RO87007A (en) PROCESS AND INSTALLATION FOR THE PREPARATION OF ISOMEROSIS
RO79428A2 (en) DRUG COMPOSITION FOR THE TREATMENT OF DERMATOSES
FR2334362A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERURICEMIA
FR2562798B1 (en) PHARMACEUTICAL AGENT FOR THE TREATMENT OF PSORIASIS
BE892339A (en) AGENTS FOR THE TREATMENT OF CORONARY HEART CONDITIONS
FR2536280B1 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF TUMORS
BE892781A (en) NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: COUGHLIN SHAUN R.

Effective date: 19840827